Prokidney PROK
NASDAQ PROK
$1.85 -0.14 (-7.04%)
At close: Sep 9, 2026 · 4:00 PM EDT

Prokidney (PROK) Net Shares Issued and Repurchased (2022 - 2026)

Prokidney's (PROK) quarterly Net Shares Issued and Repurchased came in at $10.9 million in Q1 2026, little changed year-over-year from $10.9 million in Q1 2025, and down 19.82% quarter-over-quarter from $13.6 million in Q4 2025.

Analysis

Prokidney (PROK) Net Shares Issued and Repurchased (2022 - 2026) Analysis & Trends

Prokidney (PROK) has reported Net Shares Issued and Repurchased for 5 consecutive years, with $10.9 million the latest figure, recorded in Q1 2026.

  • On a quarterly basis, Net Shares Issued and Repurchased changed 0.15% year-over-year to $10.9 million in Q1 2026; TTM through Mar 2026 was $10.9 million, a 0.15% change from a year earlier, with the FY2025 full-year figure at $13.6 million, up 52.9% from the prior year.
  • Net Shares Issued and Repurchased was $10.9 million for Q1 2026 at Prokidney, down from $13.6 million in the prior quarter.
  • Over five years, Net Shares Issued and Repurchased peaked at $13.6 million in Q4 2025 and troughed at $3.6 million in Q4 2022.
  • A 5-year average of $10.1 million and a median of $10.9 million in 2025 frame the typical range for Net Shares Issued and Repurchased.
  • Across the five-year window, Net Shares Issued and Repurchased soared 243.09% in 2023 and retreated 28.96% in 2024, its largest moves.
  • Over 5 years, Net Shares Issued and Repurchased stood at $3.6 million in 2022, then soared by 243.09% to $12.5 million in 2023, then dropped by 28.96% to $8.9 million in 2024, then soared by 52.9% to $13.6 million in 2025, then slipped by 19.82% to $10.9 million in 2026.
  • The last three Net Shares Issued and Repurchased figures came in at $10.9 million (Q1 2026), $13.6 million (Q4 2025), and $10.9 million (Q1 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn -
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn - -
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn -
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn -
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn -
6 Beam Therapeutics 2.65 Bn 2.65 Bn - -
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn -
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn -
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn -
10 Prokidney 346.07 Mn 346.07 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 10.88 Mn
Dec 31, 2025 13.56 Mn
Mar 31, 2025 10.89 Mn
Dec 31, 2024 8.87 Mn
Dec 31, 2023 12.49 Mn
Dec 31, 2022 3.64 Mn